Nadja I. Lorenz
Dr. Senckenberg Institute Of Neurooncology
Frankfurt Am Main, HE, Germany
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.
Journal: Cell death discovery
Published: August 18, 2025
Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma.
Journal: Molecular medicine reports
Published: February 14, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2024
An AMP-activated protein kinase-PGC-1α axis mediates metabolic plasticity in glioblastoma.
Journal: Clinical and translational medicine
Published: April 09, 2024
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.
Journal: Cell death discovery
Published: May 19, 2023
Formate promotes invasion and metastasis in reliance on lipid metabolism.
Journal: Cell reports
Published: April 29, 2022
Correction: Serine-dependent redox homeostasis regulates glioblastoma cell survival.
Journal: British journal of cancer
Published: August 07, 2021
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide.
Journal: Scientific reports
Published: February 18, 2021
Serine-dependent redox homeostasis regulates glioblastoma cell survival.
Journal: British journal of cancer
Published: September 02, 2019
AMPK activation protects astrocytes from hypoxia‑induced cell death.
Journal: International journal of molecular medicine
Published: July 20, 2019
Last Updated: 09/26/2026